This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the exams for this article:
Adult Hip Reconstruction Test 8: Total Hip Arthroplasty Results
CME 3: July, August, September 2004
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parvizi, J.
Right arrow Articles by Lewallen, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parvizi, J.
Right arrow Articles by Lewallen, D. G.
Related Collections
Right arrow Adult Hip
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 86:1983-1988 (2004)
© 2004 The Journal of Bone and Joint Surgery, Inc.

Thirty-Day Mortality Following Hip Arthroplasty for Acute Fracture

Javad Parvizi, MD1, Mark H. Ereth, MD1 and David G. Lewallen, MD1

1 Departments of Orthopedics (J.P. and D.G.L.) and Anesthesiology (M.H.E.), Mayo Clinic, 200 First Street S.W., Rochester, MN 55905. E-mail address for D.G. Lewallen: lewallen.david{at}mayo.edu

Investigation performed at the Departments of Orthopedics and Anesthesiology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.


Background: Hip fractures are associated with a substantial mortality rate. Previous reports on perioperative mortality associated with hip arthroplasty for the treatment of acute fracture have not documented demographic and surgical characteristics that increase the likelihood of death. The purpose of the present study was to determine the prevalence of, and associated risk factors for, perioperative death following hip arthroplasty for the treatment of acute fracture.

Methods: Data were compiled from the computerized total joint registry at a single institution to determine the mortality rate following hip arthroplasty according to age, gender, diagnosis, implant type, and fixation mode. A review of this database revealed that 7774 consecutive patients had undergone hip arthroplasty for the treatment of an acute fracture between 1969 and 1997. The medical records of all patients who had died within thirty days after hip arthroplasty were reviewed retrospectively.

Results: The overall mortality rate within thirty days after hip arthroplasty for the treatment of an acute fracture was 2.4% (186 of 7774), yet notable variations in the mortality rate were seen within clinical subgroups. The thirty-day mortality rate was significantly higher for patients who had received a cemented implant, female patients, elderly patients, patients with cardiorespiratory comorbidities, and patients with intertrochanteric fractures. With the numbers available, there was no significant difference in mortality between patients who had been managed with total hip arthroplasty and those who had been managed with hemiarthroplasty.

Conclusions: Hip arthroplasty for the diagnosis of acute fracture is associated with a nearly tenfold higher rate of perioperative mortality compared with elective hip arthroplasty. Medical optimization, appropriate choice of implants, and vigilant intraoperative management of these patients are essential.

Level of Evidence: Prognostic study, Level II-1 (retrospective study). See Instructions to Authors for a complete description of levels of evidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
C. Zhan, R. Kaczmarek, N. Loyo-Berrios, J. Sangl, and R. A. Bright
Incidence and Short-Term Outcomes of Primary and Revision Hip Replacement in the United States
J. Bone Joint Surg. Am., March 1, 2007; 89(3): 526 - 533.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
N. Hebela, D. G. Smith, and M. A. Keenan
What's New in Orthopaedic Rehabilitation
J. Bone Joint Surg. Am., November 1, 2004; 86(11): 2577 - 2581.
[Full Text] [PDF]

Letters to the Editor:

Read all Letters to the Editor

Thirty-day mortality following hip arthroplasty for acute fracture.
Christopher G. Moran, M.D., FRCS
JBJS Online, 12 Oct 2004 [Full text]
Thirty-day mortality following hip arthroplasty for acute fracture
David G. Lewallen, et al.
JBJS Online, 12 Oct 2004 [Full text]